Profil
Cynthia Roney has been President and Chief Executive Officer of Xillix Technologies Corp.
since June 2001.
She was President of Xillix Technologies Corp.
from November 2000 to June 2001.
She joined Xillix Technologies Corp.
as a Director of Marketing in March 1995.
She received a BA from the University of Western Ontario.
Ehemalige bekannte Positionen von Cynthia Roney
| Unternehmen | Position | Ende |
|---|---|---|
Biomerge Industries Ltd.
 Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Präsident | 01.05.2006 |
| PneuVation Medical, Inc. | Präsident | - |
Baxter Corp.
 Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Corporate Officer/Principal | - |
| NEOVASC INC. | Vertrieb & Marketing | - |
Ausbildung von Cynthia Roney
| University of Western Ontario | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Biomerge Industries Ltd.
Biomerge Industries Ltd. Medical SpecialtiesHealth Technology Biomerge Industries Ltd. is a Canadian medical device company and leader in fluorescence endoscopy for improved cancer detection. The Company’s first-generation product, Xillix LIFE-Lung™ received Pre-Market Approval (PMA) from the U.S. FDA in 1996. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. | Health Technology |
Baxter Corp.
Baxter Corp. Medical SpecialtiesHealth Technology Baxter Corp. supplies health care and laboratory products. Its products are used for treating cancer, hemophilia, immune deficiencies, kidney disease, and trauma. The company is headquartered in Mississauga, Canada | Health Technology |
Neovasc, Inc.
 Neovasc, Inc. Medical SpecialtiesHealth Technology Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada. | Health Technology |
| PneuVation Medical, Inc. |
